Results 181 to 190 of about 2,248 (205)

Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study. [PDF]

open access: yesInflamm Bowel Dis
Sands BE   +18 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

A Zona de Ossa- Morena e as suas matérias-primas críticas

Revista De Ciência Elementar, 2020
MIGUEL Maia   +2 more
exaly  

The effect of a diabetes education programme (PRIMAS) for people with type 1 diabetes: Results of a randomized trial

Diabetes Research and Clinical Practice, 2013
Bernhard Kulzer   +2 more
exaly  

Home - About - Disclaimer - Privacy